In glucose deprivation conditions, metformin sensitized cancer cells by inhibiting mitochondrial complex I, reducing the accumulation of unfolded proteins in the endoplasmic reticulum and promoting the activation of SIRT3. Here, SIRT3 is linked to cancer.